Cannabis use linked to higher paranoia when started to self‑medicate, new studies show
King’s College London and University of Bath studies show reasons for cannabis use and childhood trauma raise paranoia risk; experts urge screening now.
New research from King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and the University of Bath reports that why someone first uses cannabis influences their later risk of paranoia. The findings, drawn from the large Cannabis & Me survey, show that individuals who began using cannabis to self‑medicate for pain, anxiety, depression or early psychotic symptoms scored higher on measures of paranoia. Two companion papers also link types of childhood trauma with both heavier cannabis consumption and increased paranoia among users.
First cannabis use motive predicts later paranoia scores
Researchers analysed responses from 3,389 adults who took part in Cannabis & Me, a broad survey of current and former cannabis users. Participants reported their reasons for first trying cannabis, reasons for continued use, weekly consumption measured in THC units, and mental health symptoms including paranoia, anxiety and depression.
The paper published in BMJ Mental Health found that people who initially used cannabis to cope with illness or distress had notably higher paranoia and anxiety scores than those who began out of curiosity or social reasons. Those who tried cannabis for fun or with friends recorded the lowest average scores on paranoia and anxiety scales.
Higher weekly THC intake among self‑medicating groups
Survey respondents were also asked to estimate the frequency and strength of their cannabis so researchers could calculate average weekly THC intake. Across the sample the mean reported consumption was 206 THC units per week, an amount the authors equate roughly to 10–17 joints weekly under common 20% THC assumptions used for London samples.
Subgroups who began using to relieve anxiety or depression, or because household members used cannabis, reported substantially higher weekly THC units. Average weekly consumption in these groups reached about 248, 255 and 287 THC units respectively, suggesting heavier use tracks with motives tied to coping or social household exposure.
Childhood trauma interacts with cannabis use to elevate paranoia
A second paper, published in Psychological Medicine, used the same survey dataset to examine the relationship between childhood trauma, cannabis consumption and paranoia. Just over half of respondents reported some form of childhood trauma, and the analysis identified physical and emotional abuse as the strongest predictors of higher paranoia scores.
The study also found that certain trauma types were associated with greater THC intake, with respondents reporting sexual abuse showing markedly higher weekly consumption. Emotional abuse and household discord were particularly linked to a pattern of both increased cannabis use and heightened paranoia, indicating the interaction between trauma and substance use varies by trauma subtype.
Clinical implications and recommendations for screening
Lead authors and clinical researchers say the results carry immediate relevance for practitioners who see people presenting with paranoia or heavy cannabis use. The studies stress the importance of screening for a history of trauma in clinical assessments and of enquiring about the reasons a person began using cannabis when planning care or support.
Researchers also suggest adopting the concept of standard THC units—similar to alcohol units—to help users and clinicians track consumption and manage risk. That approach could support more consistent messaging in clinical settings and guide harm‑reduction advice for those using cannabis to cope with distress.
Policy considerations amid changing cannabis landscapes
Senior investigators cautioned that policy changes around cannabis, particularly moves toward greater legalisation, should be accompanied by public education and health support. Clinic experience reported by the research team indicates groups who turn to cannabis to manage physical or emotional pain may face amplified risks to mental health if use escalates without targeted interventions.
Authors argue that legal reform absent robust education and accessible mental health resources could increase demand on healthcare systems and worsen outcomes for vulnerable groups. They call for policymakers to consider these differential risks when designing regulatory and public health responses.
Survey scope, funding and study limitations
Cannabis & Me represents one of the largest self‑report surveys of cannabis users, and its funding came from the Medical Research Council. The sample included adults aged 18 and over and captured a wide range of use patterns and personal histories related to mental health and trauma exposure.
The authors note the data reflect cross‑sectional survey responses and self‑reported consumption, which limits causal inference and may introduce reporting biases. Nevertheless, the consistency of associations across motives for use, consumption levels, and trauma exposures supports targeted screening and further longitudinal research.
The findings underscore that not all cannabis use carries the same risk profile; starting cannabis to self‑medicate or following specific childhood traumas appears linked to heavier use and greater paranoia. Clinicians, public health officials and policymakers should consider motive‑based risk and trauma history when designing prevention, screening and education strategies.
